During the past decade, Harrison Medical Center conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 61 clinical trials were completed, i.e. on average, 44.2% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 47 clinical trials were completed. i.e. 82.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harrison Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harrison Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Harrison Medical Center" are "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Fallopian Tube Carcinoma" (8 trials), "Recurrent Primary Peritoneal Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Harrison Medical Center" in a lesser frequency.

Most popular intervention types in "Harrison Medical Center" are "Drug" (140 trials), "Other" (108 trials), "Biological" (79 trials), "Procedure" (51 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (46 trials), "Computed Tomography" (30 trials), "Carboplatin" (28 trials) and "Nivolumab" (28 trials). Other intervention names were less common.

The vast majority of trials in "Harrison Medical Center" are 139 trials for "All" genders, 39 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Harrison Medical Center". undefined are not yet recruiting, 56 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Harrison Medical Center, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Harrison Medical Center, 3 "Phase 1" clinical trials were conducted, 91 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".